Christopher C. McConkey
101 works · 5,667 citations · h-index 26
Top works
- Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region
- Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
- PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
- Treatment and follow‐up of oral dysplasia — A systematic review and meta‐analysis
- A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy
- Chemoradiotherapy for Rectal Cancer: An Updated Analysis of Factors Affecting Pathological Response
- Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials
- A Study of Information Seeking by Cancer Patients and their Carers
- Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer
- Cancer of the Large Bowel
- The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta‐analysis
- Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
- Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses
- Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
- Estrogen-receptor-directed neoadjuvant therapy for breast cancer: Results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
- Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.
- The binary oral dysplasia grading system: validity testing and suggested improvement